Inclusion Criteria:~* Subjects and their caregivers must provide informed consent prior to study entry.~*
Subjects must have a clinical diagnosis of probable mild-to-moderate Alzheimer's disease with no evidence of
disorders that are thought to be the cause of, or contributing to the severity of the subject's dementia and a
documented history of at least 6 months of ongoing donepezil therapy with stable dosing for at least the last 2
months.~* Subjects must have a regular caregiver who is willing to attend visits, oversee the subject's
compliance with the study and report on the subject's status.~* Female subjects of child-bearing potential must
agree to abstinence or an approved form of birth control.~* Subjects must have adequate blood pressure and
laboratory values.~
